trihexyphenidyl has been researched along with Alzheimer Disease in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salganik, I | 1 |
1 other study available for trihexyphenidyl and Alzheimer Disease
| Article | Year |
|---|---|
[The release of growth hormone in response to injection of trihexiphenidyl in patients with Alzheimer's disease, multi infarction dementia and in schizophrenic patients with intact cognitive functions (preliminary results)].
Topics: Aged; Alzheimer Disease; Brain; Cholinergic Antagonists; Cognition; Dementia, Multi-Infarct; Diagnos | 1999 |